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Glial cells  are a large com ponent o f the develop ing  nervous  
system , appearing  before the  onset of axon outgrow th in a 
variety  of developing system s. Their tim e o f a p p e aran ce  and  
the ir location in conjunction with developing axon pathw ays  
m ay allow  them  to  d efin e  the  position o f axon pathw ays. 
Specific  glial cells  m ay be u tilized as gu ideposts by growing  
axons, allow ing them  to recogn ize  the  appropria te  pathw ay, 
or conversely, glial cells m ay inhibit axons from  growing  
along an inappropriate  pathw ay. Th e  7F7 m onoclonal anti­
body labels  a subset of glial cells  in grasshopper em bryos  
tha t m ay play a role in defin ing the  location o f se lected  
axonal pathw ays. This  antibody recogn izes the  R E G A -1 m ol­
ecu le, a  ce ll-su rface  antigen w ith a m olecular w eight o f 60  
kDa, which is regionally exp ressed  on develop ing  glial cells. 
REG A-1 is expressed  around the edges o f clusters of glial 
cells  and on lam ellae extending from  glial cells  to line the  
edges  of som e axonal pathw ays. R EG A-1 expression is first 
seen in the neuroblast sheet, surrounding neuroblast 4 -1 . 
Slightly la ter in developm ent, 2 glial ce lls  exten d  processes  
tha t e xpress REG A-1 and d em a rcate  the caudal ed g e  of the  
anterior com m issure. A s the  anim al m atures, cell p rocesses  
expressing REG A-1 line the  edges of the  longitudinal con­
nective, then expand to surround the  central neuropil o f the  
segm ental ganglia. REG A-1 expression is a lso  seen in con­
junction with axons leaving the  segm ental ganglia via the  
segmental nerves and the intersegmental connectives. REGA-1 
expression is lim ited to a  subset o f glial cells; som e known  
glial cells  such as  the  segm ent boundary cell do not express  
R E G A -1 . G lial cell processes expressing  REG A-1 are  seen  
only in association w ith axons, which suggests that these  
processes m ay a c t as  borders or guard rails confining axons  
to the appropriate  regions of the  develop ing  CNS. Axons  
navigating a  path through the  CNS m ay be prohibited from  
growing into inappropriate  regions based on their inability  
to cross the  boundaries estab lished  by glial cells  expressing  
R EG A -1.
During the development of the CNS growing axons encounter 
a wide variety of cellular and noncellular substrates that may 
provide pathway cues for developing neurons. Glial cells form
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a large component of the developing CNS, and recent evidence 
has implicated them in defining the location of developing neu­
ral pathways in vertebrates (Silver et al., 1982; Poston et al.,
1988) and invertebrates (Bastiani and Goodman, 1986; Jacobs 
and Goodman, 1989). In vertebrates, glial cells may provide 
permissive substrates for axonal growth, allowing the formation 
of such pathways as the corpus callosum (Silver et al., 1982), 
or they may form boundaries inhibiting axons from entering 
inappropriate regions (Silver et al., 1987; Poston et al., 1988). 
Glial cells may provide permissive substrates for axon growth 
by expressing surface molecules that allow axons to recognize 
or adhere to them (Silver and Rutishauser, 1984; Johnson et 
al., 1988). Conversely, glial cells may act to inhibit axon growth 
into inappropriate regions of the CNS by the expression of in­
hibitory molecules (Caroni and Schwab, 1988).
Invertebrate glial cells have also been shown to play a role in 
the formation of axon pathways. Recent observations have sug­
gested that there exists a glial scaffold that marks the presump­
tive location of axonal pathways before the onset of axon growth 
in insects (Bastiani and Goodman, 1986; Jacobs and Goodman,
1989). In Drosophila, this scaffold is composed of pairs of elon­
gate glial cells positioned in the regions where the anterior and 
posterior commissures and the longitudinal connectives will 
form in the segmental ganglia (Jacobs and Goodman, 1989). 
Another glial cell, the segment boundary cell, has been observed 
in association with the developing intersegmental nerve in Dro­
sophila and in grasshoppers (Goodman et al., 1984; Bastiani 
and Goodman, 1986). During development, axons that pioneer 
the connectives, commissures, and the intersegmental nerve 
make extensive contact with these early glial cells. Additionally, 
experimental manipulations in the grasshopper embryo suggest 
that the segment boundary cell is required for the correct for­
mation of the intersegmental nerve, because it provides guid­
ance cues necessary for the anterior comer cell (aCC) neuron to 
grow into the intersegmental nerve (Bastiani and Goodman,
1986). These cues are likely to be manifested by the expression 
of molecules on the surface of the segment boundary cell that 
can be recognized by the aCC neuron, allowing it to make an 
appropriate pathway choice. These observations illustrate that 
glial cells are positioned appropriately to act in defining the 
location of axonal pathways in invertebrates, mirroring the ob­
servations made in vertebrate systems.
The developmental origins of insect glial cells are largely un­
known. It has been suggested that glial cells arise from dedicated 
glial precursor cells, elements of the neuroblast sheet whose 
progeny populate the segmental ganglia as glial cells. One such 
precursor, whose progeny appear to give rise to some neuropilar 
glial cells, is located at the lateral edge of the neuroblast sheet 
(Doe and Goodman, 1985). Alternatively, neuroblasts them­
selves may be capable of giving rise to glial cells. Such dual
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offspring stemming from a single progenitor have been seen in 
the development of the vertebrate CNS (Wetts et al., 1989); 
invertebrate glia may arise in the same manner. Glial cells may 
also arise from neuroepithelial cells that do not differentiate into 
neuroblasts. Each neuroblast within the developing neuroepi­
thelium is surrounded by non-neuronal sheath and cap cells 
(Doe and Goodman, 1985; Doe et al., 1985), which may later 
develop into glial cells. Additional non-neuronal cells may arise 
along the midline of the neuroepithelium. Unpaired midline 
precursor cells, the midline ectodermal cells, give rise to midline 
precursor (MP) neurons (Bate, 1976; Doe and Goodman, 1985); 
additionally, they give rise to midline glial cells (Campos-Ortega 
and Hartenstein, 1985; Jacobs and Goodman, 1989). It is also 
possible that different morphological types of glial cells may 
stem from different progenitor populations (Shepherd and Bate,
1990).
Considerably more is known about the location and distri­
bution of glial cells in adult insect ganglia. Glial cells compose 
a large part of the adult insect CNS and have been classified 
into various subtypes based on morphological and positional 
criteria (Wigglesworth, 1959; Lane, 1974; Radojcic and Pen- 
treath, 1979; Hoyle, 1986). Subtypes of glial cells have been 
recognized that wrap and isolate neuronal somata, that separate 
the central neuropil from the surrounding neuronal cell bodies, 
and that are associated with axons in the neuropil, the longi­
tudinal connectives, and the peripheral nerves (Hoyle, 1986).
The early appearance of invertebrate glial cells and their close 
association with developing axon pathways suggest that glial 
cells may play a role in specifying the location of these axonal 
pathways, and that axons must be able to recognize and respond 
appropriately to glial cells in order to grow along the correct 
pathway. This suggests that there are likely to be differences 
among glial cells associated with different pathways. These dif­
ferences are likely to be manifested by the differential expression 
of cell-surface molecules that can interact with axons to provide 
the necessary guidance cues. We have begun to identify and 
characterize specific non-neuronal cells associated with deve­
loping CNS pathways in grasshopper embryos. We have isolated 
a monoclonal antibody that recognizes the regionally expressed 
glial antigen-1 molecule (REGA-1) expressed on a subset of glial 
cells associated with developing axonal pathways. REGA-1 ex­
pression on these cells begins early in development in specific 
regions of the CNS where a nerve pathway will eventually form, 
preceding the appearance of axons in this pathway. At later 
stages of development, REGA-1 is expressed in association with 
other pathways, then expands to line the developing neuropil 
in the region where neuropilar glial cells are located in adult 
segmental ganglia. The expression of this antigen on specific 
glial cells suggests that these cells and, consequently, the ex­
pressed antigen may play a role in defining the location of early 
nerve pathways.
M aterials an d  M ethods
Generation o f the 7F7 monoclonal antibody. Ventral nerve cords were 
dissected from 30 55% grasshopper embryos into cold Ringer’s solution. 
Nerve cords were homogenized in phosphate-bulfered saline (PBS) con­
taining 1 mM phenylmethylsulfonyl fluoride (PMSF) with the addition 
of protease inhibitors [PI; 1 Mg/ml each of antipain, chymostatin, leu- 
peptin, pepstatin, JV-p-tosyl-L-lysine chloromethyl ketone (TLCK), and 
7V-tosyl-L-phenylalanine chloromethyl ketone (TPCK)] and centrifuged 
at 1000 x g  (4°C) for 10 min to separate out nuclei and cellular organ­
elles. The supernatant was centrifuged at 200,000 x g  (4°C) for 30 min, 
and the resulting membrane pellet was resuspended in 100 /ul PBS,
emulsified with an equal volume of Freund’s adjuvant, and injected 
intraperitoneally into a female Balb/C mouse. The first injection con­
tained Freund’s complete adjuvant; subsequent injections were made 
using Freund’s incomplete adjuvant with the exception of the final in­
jection 3 d prior to fusion, which was without adjuvant. The mouse 
received 4 injections spaced 2 weeks apart. Spleen cells from the injected 
mouse were fused with NS-1 myeloma cells using the procedure of 
Kohler and Milstein (1975). Hybridoma colonies were grown in tissue 
culture medium consisting of 70% RPMI 1640 (Cellgro), 20% bovine 
calf serum (Hyclone), and 10% NCTC-135 medium with L-glutamine 
(Gibco), with the addition of 0.1 mM nonessential amino acid stock 
solution (Gibco), 0.2 IU/ml bovine insulin (Sigma), 1 mM oxaloacetate 
(Sigma), and 1 x hypoxanthine-thymidine (HT) solution (Gibco). Un­
diluted supematants from the hybridoma colonies were screened on 
40% whole-mount grasshopper embryos using the immunohistochem­
istry protocol outlined below. The colony secreting the 7F7 monoclonal 
antibody was selected for further study based on its selective labeling 
of a very small portion of the CNS in a 40% grasshopper embryo.
Hybridoma cells that produced the 7F7 antibody were used for the 
production of ascites fluid. Adult male Balb/C mice were primed with 
an intraperitoneal injection of Pristane (2,6,10,14-tetramethyl penta- 
decane; Sigma) 1 week prior to injection of hybridoma cells. Approx­
imately 3 x 105 hybridoma cells were injected intraperitoneally into 
each primed mouse. Ascites fluid was harvested 10 d later by tapping 
the enlarged abdomen of the mouse with a sterile 20-ga syringe needle. 
Ascites fluid containing the 7F7 antibody was used for all subsequent 
experiments.
Immunohistochemistry. For immunohistochemistry of sections 
through adult ganglia, segmental ganglia were dissected from adult grass­
hoppers and fixed in 2% paraformaldehyde in Millonig’s buffer. Ganglia 
were fixed for 4 hr, washed in PBS, and immersed overnight in 20% 
sucrose. The following day, the ganglia were embedded in liquid gel 
albumin, hardened, and trimmed to remove excess gelatin. Matrix blocks 
containing the ganglia were positioned on a cryostat chuck and frozen 
in place using OCT (Miles). Blocks were allowed to equilibrate at -  20°C, 
then 8-Mm sections were cut on a Slee cryostat and mounted by drying 
onto gelatin-coated slides. Tissues were fixed to the slides by immersion 
in 10% buffered formalin, washed in PBS with the addition of 1 mg/ 
ml glycine, and incubated in a blocking solution consisting of 10% goat 
serum and 0.3% saponin in PBS. Primary antibody, diluted in blocking 
solution, was applied to the sections, and the slides were incubated in 
a humidified chamber overnight at 4°C. The next day, sections were 
washed in PBS, rinsed in blocking solution, incubated in secondary 
antibody for 2-4 hr at room temperature, washed briefly in PBS, in­
cubated in 1 mg/ml diaminobenzidine (DAB; Sigma), reacted with the 
addition of 0.003% H20 2, and coverslipped with 90% glycerol in PBS. 
Sections were viewed on a Leitz Diaplan microscope using Nomarski 
optics.
Grasshopper embryos, obtained from a colony of Schistocerca amer­
icana maintained at the University of Utah, were prepared for im­
munohistochemistry by dissecting them from their eggs into Ringer’s 
solution. Embryos were staged by comparison with the staging series 
prepared by Bentley et al. (1979). Embryos were transferred into 2% 
paraformaldehyde in Millonig’s buffer and fixed for 60 min. Whole 
embryos were washed, blocked, and incubated in antibodies using the 
same protocol as was used for sections of adult ganglia, then were mount­
ed in 90% glycerol and viewed using Nomarski optics or epifluorescence 
illumination.
Primary antibody dilutions were as follows: The 7F7 monoclonal 
antibody was used at a dilution of 1:500 in blocking solution, 5B12 
hybridoma supernatant (obtained from Dr. Mark Meyer at the Uni­
versity of Washington) was used at a dilution of 1:3, and fluorescein 
isothiocyanate (FITC) conjugated anti-horseradish peroxidase (Jackson 
Immunoresearch) was used at 1:500. Secondary antibodies [rhodamine 
isothiocyanate- (RITC), or HRP-conjugated goat anti-mouse antibod­
ies; Jackson Immunoresearch] were applied at a dilution of 1:200 in 
blocking solution. HRP-conjugated secondary antibodies were visual­
ized by incubation 1 mg/ml DAB followed by reaction with 0.003%
h 2o 2.
Electron microscopy. Thirty-five percent grasshopper embryos were 
dissected under sterile conditions into embryo culture medium con­
taining 50% Schneider’s Drosophila medium (Gibco), 40% minimum 
essential medium (MEM; Gibco), 10% heat-treated fetal calf serum 
(Hyclone), 1.5 mg/ml bovine insulin (Sigma), 0.03 mg/ml glycine (Sig­
ma), 0.001 mg/ml juvenile hormone (Sigma), 0.001 mg/ml ^-ecdyste-
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rone (Sigma), and 10,000 U/ml antimycotic/antibiotic (Sigma). Live 
embryos were pinned onto glass slides, then incubated in embryo culture 
medium in the presence of 7F7 monoclonal antibodies (1:100) at 30°C 
for 2 hr. Embryos were rinsed in fresh medium and incubated in culture 
medium with the addition of secondary antibody (HRP-conjugated goat 
anti-mouse, diluted 1:50). Embryos were fixed in 2% paraformaldehyde 
and 0.5% glutaraldehyde for 30 min, washed, intensified by incubation 
in 0.2% cobalt chloride, and reacted with DAB with the addition of 
/3-D-glucose and glucose oxidase to provide the H20 2 necessary for the 
reaction (Watson and Burrows, 1981). Embryos were postfixed in 1% 
paraformaldehyde and 1% glutaraldehyde, en bloc stained with uranyl 
acetate, dehydrated in graded ethanol, and embedded in Spurr’s resin. 
Sections were cut on a Reichardt-Jung microtome, mounted on Form- 
var-coated single slot grids, and viewed in a Philips 201 electron mi­
croscope.
Immunoprecipitation. The antigen recognized by the 7F7 antibody 
was immunoprecipitated from a membrane preparation made from 40% 
grasshopper embryos. Forty percent grasshopper embryos were dis­
sected into cold RPMI 1640 (Cellgro) with the addition of 6 mg/ml 
glycine. Embryos were washed in 10 mM triethanolamine (TEA) and 5 
mM EDTA with the addition of protease inhibitors and homogenized. 
The homogenate was spun at 1000 x g  to remove the nuclei and cellular 
organelles, then the supernatant was removed and spun at 200,000 x 
g  to pellet the membrane fraction. The pellet was resuspended in 10 
mM TEA and radiolabeled with 1251 using lactoperoxidase (Haustein et 
al., 1975). Immunoprecipitation was performed using previously de­
scribed methods (Patel et al., 1987); the isolated antigen was run on a 
12.5% polyacrylamide gel in the presence of sodium dodecyl sulfate 
(SDS) and visualized by overnight exposure to Kodak X-OMAT x-ray 
film using an intensifier screen.
Affinity purification. A monoclonal affinity column column was pre­
pared by coupling 7F7 antibodies to protein G-coated Sepharose beads 
(Pharmacia) using dimethylpimilimidate (Harlow and Lane, 1988). The 
antigen was extracted from grasshopper embryo lysate made from 40% 
grasshopper embryos. Lysate was made by extruding the embryos from 
their eggs into PBS with added protease inhibitors (PI; see above). 
Crushed embryos were separated from yolk by centrifugation at 17,000 
x g  for 30 min; the resulting pellet was resuspended in lysate buffer [10 
mM TEA, 0.15 m NaCl, 2% Nonidet P-40 (NP-40), 0.5% deoxycholate 
(DOC), pH 8.2, plus PI] and stirred for 60 min at 4°C. The suspension 
was centrifuged again to remove the insoluble fraction, and the resulting 
supernatant was filtered through gauze, then frozen at -  70°C until need­
ed. Thawed lysate was spun at 200,000 x g, then passed over the column 
at a rate of 200 ml/24 hr. After exposure to lysate, the column was 
washed 4 times at pH 8.2 using the following buffers: (1)10 mM TEA, 
0.15 m, NaCl, 1% NP-40, plus PI; (2) 10 mM TEA, 0.15 m NaCl, plus 
PI; (3) 10 mM TEA, 0.15 m NaCl, 0.5% DOC, plus PI; and (4) 10 mM 
TEA, 1.0 m NaCl, 1% NP-40, plus PI. The 7F7 antigen was eluted from 
the column under high-pH conditions (elution buffer contained 50 mM 
TEA, 0.15 M NaCl, 1% NP-40, pH 11.5, plus PI) in 1-ml aliquots, 
precipitated using trichloroacetic acid, and run on 10% polyacrylamide 
gels in the presence of SDS. Proteins were visualized using Coomassie 
blue or silver staining. Molecular-weight standards (Bio-Rad, 14.5-200 
kDa) were run with each gel.
Generation o f polyclonal serum. Polyclonal antibodies were produced 
to isolated column fractions by immunizing Balb/C female mice with 
whole-column fractions (approximately 10 Mg protein per injection). 
Column fractions were precipitated with trichloroacetic acid, washed 
in acetone, then lyophilized. Dry proteins were resuspended in PBS, 
emulsified with an equal volume of Freund’s adjuvant, then injected 
intraperitoneally. The first injection was made using Freund’s complete 
adjuvant; subsequent injections 2 weeks apart were made using incom­
plete adjuvant. Serum was collected from mice 1 week after each in­
jection by bleeding from the tail vein, then used at a dilution of 1:500 
to label grasshopper embryos as above.
R esu lts
Immunohistochemical characterization o f the 7F7 antigen 
Initial screening of hybridoma culture supernatant containing 
the 7F7 antibody suggested that the antibody recognized some 
specific elements of the embryonic grasshopper CNS. To de­
termine what cells or types of cells the antibody was recognizing, 
we labeled sections through adult segmental ganglia and whole-
mount embryos at 40% of development using the 7F7 antibody 
and compared the labeling pattern to that obtained using pre­
viously characterized antibodies.
In adult segmental ganglia, the 7F7 antibody labels a discrete 
ring surrounding the central neuropil (Fig. IA). This ring cor­
responds to the position of the neuropilar glial cells, a ring of 
glial cell bodies surrounding the central neuropil that extend 
processes into the neuropil (Hoyle, 1986). Double labeling using 
Hoechst 33258, a fluorescent nuclear dye, and the 7F7 antibody 
indicates that 7F7 antibody labeling colocalizes with the posi­
tion of a ring of glial nuclei surrounding the neuropil, but does 
not label other glial cell bodies, such as the perineural glial cells, 
which are located external to the neuronal cell bodies (data not 
shown). 7F7 antibody labeling of adult ganglia is not confined 
to the region where the neuropilar glial cell bodies are located, 
but extends into the central neuropil and along the longitudinal 
connectives and segmental nerves (Fig. IA,C). Within the cen­
tral neuropil, 7F7 antibody labeling was restricted to axonal 
tracts; synaptic neuropil was unlabeled. Labeling was continu­
ously associated with axons as they coursed through the central 
neuropil and then entered the longitudinal connectives, or as 
they passed laterally into the segmental nerves. Similar sections 
of adult ganglia were labeled with the 5B12 monoclonal anti­
body, which recognizes glial cells in cricket ganglia (Meyer et 
al., 1988) and which cross-reacts with grasshoppers (Meyer and 
Edwards, 1989). Comparison of the 7F7 antibody labeling pat­
tern with the 5B12 antibody labeling pattern (Fig. 1) shows that 
there is overlap between the 2 labeling patterns, suggesting that 
the 2 antibodies are labeling some of the same structures. The 
5B12 antibody strongly labels the neuropilar glial cells, which 
also label with the 7F7 antibody. The 5B12 antibody also labels 
some structures within the central neuropil, but does not label 
the longitudinal connectives. 5B12 antibody labeling in the cen­
tral neuropil is restricted to sensory nerve tracts (Meyer et al.,
1987); 7F7 antibody labeling is more widespread, suggesting it 
labels both sensory and motor tracts. This labeling may be of 
glial cell processes associated with individual axonal tracts.
7F7 antibody labeling was also compared to 5B12 antibody 
labeling in grasshopper embryos. During embryonic develop­
ment, the labeling pattern using the 5B12 antibody is dilferent 
from the 7F7 antibody labeling pattern. The 5B12 antibody 
labels several axonal tracts within the anterior and posterior 
commissures (Meyer et al., 1988). The 5B12 antibody does not 
label the crescent-shaped structures described above, nor does 
it label any laterally positioned cell clusters (data not shown). 
While it is likely that the 5B12 and 7F7 monoclonal antibodies 
both label glial cells, it is unlikely that, in developing embryos, 
the 2 antibodies are labeling the same glial cells.
The embryonic pattern of 7F7 antibody labeling was com­
pared to labeling using antibodies against HRP (anti-HRP), which 
recognizes all insect neurons (Jan and Jan, 1982). The anti-HRP 
antibodies were directly coupled to an FITC tag; 7F7 antibody 
labeling was visualized by using an RITC-conjugated goat anti­
mouse secondary antibody. A single thoracic ganglion of a dou­
ble-labeled 35% grasshopper embryo is illustrated in Figure 2. 
Anti-HRP antibodies label all neuronal cell bodies and axons 
within the segmental ganglia and interganglionic connectives of 
the developing CNS (Fig. 2A). Neuronal cell bodies are clustered 
in the region surrounding the intersection of anterior and pos­
terior commissures with the longitudinal connective in each 
hemisegment and are strung along the length of the longitudinal 
connectives. There are several cell clusters located adjacent to
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Figure 1. Labeling of adult segmental ganglia using 7F7 and 5B12 monoclonal antibodies. Horizontal cryostat sections through adult segmental 
ganglia were labeled using the 7F7 (A, C) or 5B12 (B, D) monoclonal antibodies. A and B, Low magnification views of whole sections of segmental 
ganglia illustrate that both the 7F7 and the 5B12 antibodies label the neuropilar glial ring surrounding the central neuropil (arrowheads). Both 
antibodies also label axonal tracts within the neuropil (asterisks). Scale bars, 100 pm. C, Higher magnification of the posterolateral edge of a ganglion 
labeled with the 7F7 antibody. Labeling is seen in the ring of neuropilar glial cells (arrowheads) and extending into the longitudinal connective (I). 
Neuronal cell bodies (/>) are not labeled. Scale bar, 20 jim. D, Higher magnification of the posterolateral edge of a ganglion labeled with the SB 12 
antibody. Labeling is seen in the ring of neuropilar glial cells (arrowheads), but not in the longitudinal connective (!) or associated with neuronal 
cell bodies («). Scalc bar, 20 pm.
the labeled neuronal cell bodies in each hemiganglion that do 
not label with the anti-HRP antibodies. One cluster is positioned 
laterally in the hemiganglion, immediately anterior to the 
emerging segmental nerve (Fig. 2A); a second cluster is at the 
anteromedial edge of the ganglion, just medial to the longitu­
dinal connective (Fig. 2A). Examination of the same ganglion 
labeled with the 7F7 antibody shows that these clusters do label 
with the 7F7 antibody (Fig. IB). Additional 7F7 antibody-la­
beled cell clusters that do not label with anti-HRP antibodies 
are seen in association with the longitudinal connectives, located 
midway between 2 adjacent ganglia (Fig. 2A.B). At least one of 
these longitudinal connective-associated clusters appears to ex­
tend a lamella that lines part of the lateral edge of the connective 
(Fig. 2B). At this stage of development, the most prominent 
7F7 antibody labeling appears in 2 roughly crescent-shaped 
patches that are positioned at the posterolateral margins of the 
anterior commissure. The identity of these structures will be
discussed below. The patterns of labeling using anti-HRP and 
7F7 antibodies appear to be nonoverlapping; that is, cells labeled 
with the 7F7 antibody are not labeled with anti-HRP. This 
nonoverlapping pattern suggests that the 7F7 antibody is la­
beling a non-neuronal population of cells that are likely to be 
glial cells.
Developmental expression o f the 7F7 antigen
7F7 antigen expression in the CNS first appears at 25% of de­
velopment. At this time in development, antigen expression is 
apparent within the ventral neuroblast sheet, where labeling is 
seen around some, but not all, neuroblasts (Fig. 3A). Labeling 
appears most prominent around a single medial neuroblast in 
each hemiganglion, neuroblast 4-1 (see Doe and Goodman, 1985, 
for terminology). Light labeling is occasionally seen around neu­
roblasts 5-1 and 6-1, as well (data not shown). The labeling 
appears diffusely distributed around the edges of the neuroblasts,
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suggesting that it is the sheath cells surrounding the neuroblasts 
that are recognized by the antibody, and not the neuroblasts 
themselves. Additional labeling is also seen outside the CNS, 
primarily at the interface between the ectoderm and mesoderm 
in the developing limb buds.
By 30% of development, a prominent patch of labeling ap­
pears in the region of the embryo where the anterior commissure 
will form. Labeling is of 2 roughly crescent-shaped structures 
located at what will be the caudolateral margin of the anterior 
commissure, where the commissure will eventually intersect 
with the longitudinal connective (Fig. 3B). Focusing through the 
crescents using Nomarski optics shows that the 7F7 antibody 
labeling is restricted to lamellar processes extending dorsally 
and laterally from more ventrally and medially located cell bod­
ies (Fig. 4). These lamellar processes wrap around 2 cell bodies 
lying medial to the developing longitudinal connective and im­
mediately posterior to the presumptive location of the anterior 
commissure. At this point in development, no axons have yet 
entered the anterior commissure, suggesting that the crescents 
may delimit the caudal margin of this pathway. Based on their 
location in association with the anterior commissure and on 
their expression of a non-neuronal antigen, we have named the 
cells that give rise to the crescents the anterior commissural glial 
(ACG) cells.
7F7 antibody labeling is more extensive at 35% of develop­
ment. Labeling of the ACG crescents associated with the anterior 
commissure is apparent, as is labeling around the edges of a 
cluster of 6-8  cells positioned immediately rostral to the anterior 
commissure (Fig. 3C). This cell cluster is positioned in such a 
way that it might mark the rostral edge of the anterior com­
missure. By this point in development, several axons have en­
tered the commissure and have crossed the midline to the con­
tralateral side of the ganglion. Additional labeled cell clusters 
are located more laterally in each hemiganglion and in associ­
ation with the longitudinal connectives (Figs. IB, 3C). It is 
difficult to distinguish individual cells within these cell clusters 
based on their 7F7 antibody labeling, though the edges of the 
clusters are clearly labeled. This suggests either that the 7F7 
antigen is regionally expressed on the edges of cells, or that the 
antibody is labeling a cell process that wraps around these cell 
clusters. Some of the labeled clusters extend labeled lamellar 
processes that line the edges of developing axon tracts. The cell 
cluster located lateral to the longitudinal connectives extends a 
lamellar process that lines the lateral edge of the developing 
connective; a similar lamella is seen lining the dorsal edge of 
the emerging segmental nerve (Figs. 2B, 3 C). These lamellae, 
positioned in association with developing nerve tracts, may act 
as borders or limiting membranes to confine axons to specific 
regions within the developing ganglion.
7F7 antibody labeling appears restricted to a subset of glial 
cells within the developing ganglion. Labeling appears in as­
sociation only with the anterior commissure; there is no ho­
mologous labeling associated with the posterior commissure. 
Additionally, several identified glial cells within the developing 
ganglion do not express the antigen recognized by the 7F7 an­
tibody. These include the segment boundary cell associated with 
the intersegmental nerve (Bastiani and Goodman, 1986) and 
several large glial cells lying on the dorsal surface of the devel­
oping longitudinal connectives (cf. Bastiani and Goodman, 1986; 
Jacobs and Goodman, 1989). On those glial cells that do label 
with the 7F7 antibody, antigen expression appears to be local­
ized to specific regions of the cells. Labeling is seen around the
Figure 2. Single ganglion at 35% of embryonic development double 
labeled using anti-HRP and 7F7 antibodies. A, Anti-HRP labels all 
axons and neuronal cell bodies in the developing ganglion. Short arrows 
indicate the position of unlabeled cells that do label with the 7F7 an­
tibody (see corresponding short arrows in B). ac, anterior commissure; 
pc, posterior commissure; /, longitudinal connectives. B, The 7F7 an­
tibody labels a population of cells that does not label with anti-HRP 
(short arrows). ACG crescents (long arrows) are present at the intersec­
tion of the anterior commissure and the longitudinal connectives. Small 
arrowheads indicate labeled lamellae extending along the longitudinal 
connectives. Scale bars, 30 /im. Anterior is toward the lop of the figure; 
the midline of the animal runs through the center of each panel.
edges of cell clusters and on lamellar processes extending around 
adjacent cell bodies and along the edges of axonal tracts.
EM observation of a segmental ganglion at 40% of develop­
ment labeled using the 7F7 antibody confirms that labeling is 
regionally localized on lamellar processes extending from lightly 
labeled or unlabeled cell bodies. Live embryos at 40% of de­
velopment were labeled in culture using the 7F7 antibody, then 
were fixed and sectioned for EM observation. At this stage of 
development, labeling appears restricted to the margins of ax­
onal tracts within the developing neuropil and extends along 
the edges of the longitudinal connectives and segmental nerves 
(Fig. 4,4). The ACG crescents have shifted medially due to the 
broadening of the longitudinal connectives. EM observations
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Figure 3. Developmental progression of 7F7 antibody labeling. A. A single thoracic segment in an embryo at 25% of development. The 7F7 
antibody labels around neuroblast 4-1 in the ventral neuroblast sheet in each hemiganglion (asterisks). B, A single segment at 30% of embryonic 
development. The 7F7 antibody labels the ACG crescents (arrows) on the dorsal surface of the CNS at what will be the caudolateral edge of the 
anterior commissure. At this point in development, the MPI neuron (mp) is just beginning to extend a growth cone. C, A single thoracic segment 
at 35% of embryonic development. The 7F7 antibody labels the ACG crescents (large arrows) and clusters of cells located at the anterior margin 
of the anterior commissure and lateral to the longitudinal connective (arrowheads). Lamellae extend from some of these cell clusters to line the 
edges of the longitudinal connectives and the margin of the segmental (s) nerve (paired small arrows). D, A single ganglion at 55% of development. 
The 7F7 antibody labels the lateral margin of the neuropil (arrowheads) and the medial edges of the longitudinal connective (arrow) as it passes 
through the ganglion, ac, anterior commissure; pc. posterior commissure; 1, longitudinal connectives. Scale bars, 30 pm. In these 4 panels, anterior 
is at the top of the figure, and the midline of the animal runs down the center of each panel.
verify that the ACG cell bodies are located ventrally in the 
ganglion, adjacent to the midline (Fig. 4C). The ACG cell bodies 
are electron lucent compared to surrounding cells, consistent 
with their being glial cells (Jacobs and Goodman, 1989). The 
surfaces of these cell bodies are lightly labeled with the 7F7 
antibody, with labeling apparent only in a few patches on the 
surface of the cells (Fig. 4 Q .  The ACG cell bodies extend labeled 
processes upward adjacent to the midline. These processes turn 
laterally and lie on the dorsal surface of several more dorsally 
positioned cells in sections adjacent to that illustrated in Figure 
4C. The axons of the anterior commissure lie immediately an­
terior to this cell process and are separated from it by less than 
the diameter of a single axon. At this time in development, 
axons do not appear to lie in direct contact with the ACG cell 
process, though they are positioned so that the labeled process 
is within easy filopodial grasp. Laterally, a 7F7 antibody-labeled 
process appears to demarcate the lateral margin of the longi­
tudinal connective (Fig. AB). This process extends dorsally from 
the lateral edge of an unlabeled, electron-lucent glial cell body. 
Axons from the longitudinal connective run medial to this cell 
process, and filopodia extending from axons of the longitudinal 
connective appear to be in direct contact with the labeled pro­
cess.
By 55% of development, 7F7 antibody labeling surrounds the 
developing neuropil, approximating the position of the neuro­
pilar glial ring (Fig. 3D). There is also labeling lining the medial 
and lateral edges of the longitudinal connectives as they run 
between and through the ganglia. Labeling of the neuropil itself 
appears diffuse and not as dense as the more lateral labeling 
associated with the edges of the neuropil, and may correspond 
to labeling of glial processes extending centrally within the neu­
ropil to surround and isolate individual axon tracts. This pattern 
of expression approximates that which will be seen in the adult 
segmental ganglia (cf. Fig. \A,C).
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Figure 4. A, 7F7 antibody labeling of a single ganglion in a live embryo at 40% of development. The borders of the neuropil are outlined with 
7F7 antibody labeling (arrowheads). Arrows at B and C demarcate the plane of section illustrated in the other panels, ac, anterior commissure; pc, 
posterior commissure. Scale bar, 30 tim. B, Electron micrograph of a laterally positioned, labeled lamella (arrowheads) extending dorsally from an 
unlabeled glia cell (gc). The 7F7 antibody labels the surface of this lamella. Axons in the longitudinal connective (/) run medially to this lamella. 
ac, anterior commissure. Scale bar, 2 #zm. C, Electron micrograph of the anterior commissure glial cell bodies (acg) and their dorsally projecting 
lamellae (arrowheads). m, midline cells. Scale bar, 5 m.
Biochemical characterization o f  the 7F7 antigen
The antibody was used to immunoprecipitate the antigen from 
membranes obtained from grasshopper embryos at 40% of de­
velopment. Membrane proteins were iodinated, then solubilized 
with detergent. The antigen was precipitated by binding to a 
preformed antibody complex composed of the 7F7 antibody 
and a rabbit anti-mouse secondary antibody. Following im­
munoprecipitation, the molecule recognized by the 7F7 anti­
body was analyzed by SDS-PAGE. Comparison of the results 
obtained using the 7F7 antibody to the results obtained from 
several other antibodies available in the laboratory shows that 
the 7F7 antibody recognized a single unique band having a 
molecular weight of 60 kDa (Fig. 5). The antigen was purified 
using a monoclonal affinity column. The 7F7 antibody was cou­
pled to Protein G-coated Sepharose beads, then lysate made 
from 40% grasshopper embryos was passed over the column. 
The antigen was eluted from the column at high pH; eluted 
fractions were analyzed by SDS-PAGE. This single-step puri­
fication resulted in the isolation of a single prominent band 
having a molecular weight of 60 kDa (Fig. 6). Based on the
immunohistochemical localization of this antigen to specific 
regions of glial cells, the molecule recognized by the 7F7 anti­
body was named REGA-1, for regionally expressed glial 
antigen-1 .
To confirm the identity of the purified molecule, polyclonal 
antibodies were generated in mice against whole-column frac­
tions. Polyclonal serum was used to label whole-mount 35% 
grasshopper embryos and was compared to the labeling of age- 
matched control embryos using the 7F7 monoclonal antibody. 
The polyclonal antibody labels 35% embryos in a pattern that 
is very similar to that obtained using the monoclonal antibody 
(Fig. 7). The polyclonal antibody labels the ACG crescents as­
sociated with the anterior commissure as well as a subset of 
cells within the developing ganglion. It also labels lamellar pro­
cesses lining the lateral margins of the developing neuropil and 
longitudinal connectives. In general, labeling using the poly­
clonal antibody appears to be slightly more widespread than 
labeling using the monoclonal antibody, but the patterns of 
labeling using the 2 antibodies are very similar, suggesting that 
both antibodies are recognizing the same molecule. The more 
widespread labeling using the polyclonal may be due to a variety
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Figure 6. Silver-stained 10% polyacrylamide gel demonstrating affinity 
purification of REGA-1. REGA-1, the predominant band recognized 
by the 7F7 antibody, has a molecular weight of 60 kDa (arrow). M, 
molecular-weight markers; L, whole-embryo lysate. Molecular-weight 
marker weights are given in Figure 5, caption.
Figure 5. Autoradiograph of immunoprecipitation of REGA-1 from 
a membrane preparation made from 40% grasshopper embryos. The 
7F7 antibody recognizes a single unique band at 60 kDa (arrow). 3BI1 
is positive control (fasciclin 1); 13E10 is the negative control demon­
strating nonspecific trapping by the preformed complex. Tick marks 
along the left are molecular-weight markers in descending order: 200, 
116, 97, 66, 43, 31, and 21.5 kDa.
of shared epitopes recognized by the polyclonal serum. The 
presence of the characteristic features of 7F7 monoclonal an­
tibody labeling including the ACG crescents and lamellae as­
sociated with axonal tracts is seen following labeling using the 
polyclonal antibody. This suggests that the polyclonal antibody 
does recognize the REGA-1 molecule and confirms that the 60- 
kDa band isolated by affinity purification is indeed REGA-1.
D iscussion
REGA-1 is expressed on a subset o f  glial cells 
REGA-1 is expressed on localized regions of a unique subset of 
non-neuronal cells in the developing nervous system of the 
grasshopper embryo. The 7F7 antibody, which recognizes 
REGA-1, labels known glial structures in adult segmental gan­
glia. This is shown both on the basis of localization of the 
labeling to a ring of cell bodies in the position of the neuropilar 
glial cells (Hoyle, 1986) and on the basis of labeling in regions 
recognized by the 5B12 antibody, a known insect glial label 
(Meyer etal., 1988). REGA-1 is present on clusters of cell bodies 
in the embryonic nervous system that are not recognized by the 
anti-HRP antibody, also suggesting its non-neuronal or glial 
expression. The morphology of some of the cells expressing 
REGA-1 is typical of glial morphology. Some cells extend pro­
cesses that wrap around other cell bodies, as seen in the cres­
cents; other cells or clusters of cells extend lamellae that line 
the edges of axonal pathways such as the longitudinal connec­
tive. These observations all suggest that REGA-1 is expressed 
on a population of glial cells within the developing CNS of 
grasshopper embryos.
REGA-1 expression is restricted to selected cell clusters within 
the developing CNS, which include some, but not all, of the 
CNS glial cells. Other known glial cells do not express REGA- 
1, including the well-described segment boundary cell (Bastiani 
and Goodman, 1986). The 7F7 antibody detects a molecular
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heterogeneity that was only presumed to exist within the glial 
population of the embryonic grasshopper nervous system. Mor­
phological heterogeneity among glial cells has been extensively 
described in the adult insect CNS (Wigglesworth, 1959; Lane, 
1974; Hoyle, 1986); there is no reason to suppose that a similar 
heterogeneity could not exist among embryonic glial cells. We 
suggest that the 7F7 antibody is able to detect such heteroge­
neity. It could be argued that the 7F7 antibody is recognizing 
differentiated glial cells arising from an undifferentiated glial 
precursor population. Yet, if this were the case, one would expect 
to see an increase in 7F7 antibody labeling throughout devel­
opment as more and more mature glial cells are recruited from 
a precursor population. While this is to some extent true, as is 
seen in the increase of antigen expression in the neuropilar glial 
ring, certain identified glial cells, such as the segment boundary 
cell, do not express REGA-1. Additionally, there are entire pop­
ulations of glial cells in the adult ganglion, such as the perineural 
glia, that also do not express REGA-1.
Glial heterogeneity may arise in several different ways. Dis­
tinct types of glial cells may arise from separate precursor pop­
ulations, or they may arise from the same precursor and differ­
entiate into different classes of glial cells as they mature and 
assume a glial phenotype. Previous work has dcscribcd glial 
precursor cells located laterally within the neuroblast sheet (Doe 
and Goodman, 1985). 7F7 antibody labeling is apparent at early 
stages in the neuroblast sheet, but in a different position from 
that described for these other glial precursors. This suggests that 
there may be several distinct glial precursors, each of which 
gives rise to a different type of mature glial cell. This idea is 
further supported by progenitor labeling studies that can sepa­
rate different populations of glial cells depending on their time 
of appearance (Shepherd and Bate, 1990).
This heterogeneity suggests that all glial cells are not created 
equal, and that they have features that may be differentiated 
both morphologically and immunologically. This, in turn, sets 
the stage for the potential use of glial cells as pathway markers 
for axon guidance. The glial cells expressing REG A-1 are ideal 
candidates to provide guidance cues for growing axons. The 
features that make them attractive for this purpose are their 
limited distribution, their appearance before the onset of axon 
outgrowth, and their intimate association with selected axonal 
pathways. The fact that they are not uniformly distributed along 
all pathways of axonal growth argues against the idea that they 
are simply providing is a favorable substrate for growth. Instead, 
our data support the idea that 7F7 antibody-labeled glial cells 
may play a more defined role in shaping the axonal pathways 
of the developing CNS.
Glial cells expressing REGA-1 delineate the margins o f  
som e axonal pathways
Glial cells expressing REGA-1 are positioned appropriately both 
spatially and temporally to play a role in establishing the lo­
cation of some axonal pathways within the developing grass­
hopper CNS. REGA-1 expression appears early in the CNS, first 
around neuroblasts within the neuroepithelial sheet, then on 2 
distinctive crescents arising from the ACG cells at the caudal 
border of the developing anterior commissure. The ACG cres­
cents are located in a position to demarcate the caudal border 
of the anterior commissure; additionally, their appearance pre­
cedes the growth of axons into the anterior commissure. Cell 
processes expressing REGA-1 are also seen along the edges of 
the longitudinal connectives and the segmental nerves, sug-
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Figure 7. Immunohistochemical labeling of single ganglion at 35% of 
development using polyclonal antibody generated against column frac­
tions isolated from 7F7 monoclonal antibody affinity column. Several 
features of the 7F7 antibody labeling pattern, such as the ACG crescents 
(arrows) and the lamellae lining the lateral edges of the longitudinal 
connectives and the segmental nerve {paired small arrows), are labeled 
using this polyclonal antibody, ac, anterior commissure; pc, posterior 
commissure. Scale bar, 30 *im.
gesting that labeled processes may play a role in marking the 
borders of these pathways, as well. Late in development and in 
adults, REGA-1 expression is limited to those glial cells that 
are associated with the central neuropil and with the longitudinal 
connectives and segmental nerves. In all of these regions, 
REGA-1 may be expressed only on those glial cells associated 
with axons.
The morphology of cells and cell clusters that express REGA-1 
and are associated with axonal pathways suggests that these cells 
may play a role in defining or establishing the positions of se­
lected axonal pathways within the developing CNS. In several 
cases, these cells have been seen to extend lamellae that line the 
edges of axonal pathways such as the anterior commissure and 
the longitudinal connectives. We suggest that these lamellae may 
act as borders or guard rails to delimit the margins of some 
axonal pathways, acting to prevent axons from growing outside 
of the appropriate regions. Similar structures have been iden­
tified in vertebrate embryos (Silver et al., 1987), and similar 
inhibitory functions have been ascribed to vertebrate CNS glial 
cells (Caroni and Schwab, 1988). As development proceeds, cells 
expressing REGA-1 develop into at least part of the neuropilar 
glial ring. In adults, this ring isolates a central core of nerve 
fibers from the surrounding neuronal cell bodies. Within the 
neuropil, REGA-1 expression appears associated only with ax­
onal tracts and not with regions of synaptic neuropil, again 
potentially isolating axons from surrounding inappropriate ar­
eas. REGA-1 expression also extends out of the neuropil, but 
only in association with those axons that enter the longitudinal 
connectives or the peripheral nerves. All of these observations 
support the idea that cells expressing REGA-1 are likely to be 
those glial cells associated with axons. In addition, the inter­
actions between axons and glial cells expressing REGA-1 may 
result in the segregation of axons away from inappropriate 
regions.
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REGA-1 is regionally expressed on glial cells 
Our initial observations using light microscopy suggested that 
7F7 antibody labeling was present only on lamellar processes 
extending from unlabeled cell bodies. Our EM observations 
have supported this initial observation, showing that REGA-1 
appears regionally localized on glial cell processes closely as­
sociated with axon pathways, while the cell bodies giving rise 
to these processes either do not express this molecule or express 
it only in localized areas. These 2 observations suggest that 
REGA-1 is regionally expressed on only certain parts of glial 
cells, in particular, on the lamellar processes in close association 
with developing axonal pathways. Regional expression of cell- 
surface molecules has been described on developing Schwann 
cells (Martini and Schachner, 1986) and on developing neurons 
(Bastiani et al., 1987; Dodd et al., 1988). Regional expression 
of REGA-1 may reflect its role in the differentiation of spe­
cialized glial lamellae that may serve a specific function such as 
providing a border for axonal pathways.
Several other cell-surface molecules have been identified that 
are expressed on the surfaces of invertebrate glial cells. Our 
evidence suggests that REGA-1 is different from any previously 
described molecule. Its molecular weight (60 kDa) sets it apart 
from the antigen recognized by the 5B12 antibody, which has 
a molecular weight of 185 kDa (Meyer et al., 1988) and which 
has a different expression pattern than that demonstrated by 
REGA-1. Its molecular weight and its expression pattern are 
also different from neuroglian, a molecule with variable weights 
of 180, 167, and 155 kDa, which is expressed on neurons and 
glia in Drosophila (Bieber et al., 1989). Given that its expression 
appears limited to glial cells, REGA-1 is unlikely to be a homo- 
philic adhesion molecule like neuroglian. It may, however, play 
a role in heterophilic interactions between neurons and glia, 
possibly signaling the location of axonal pathways to the ap­
propriate neurons. Another possibility is that expression of 
REGA-1 results in establishing a nonpermissive substrate for 
axon growth (Caroni and Schwab, 1988), thus limiting axons to 
grow within certain regions. If, early in development, glial cell 
processes expressing REGA-1 act as borders to delimit the edges 
of developing axonal pathways such as the anterior commissure 
and the longitudinal connective, then the REGA-1 molecule 
may have an inhibitory function in that it may act to discourage 
axons from crossing such a border.
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